Publications by authors named "William Hansel"

Claim this Profile
A
After 65 years, research is still fun.
William Hansel

Annu Rev Anim Biosci· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From hyperkeratosis to apoptosis: lessons learned from 65 years of research.
William Hansel

Biol Reprod· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The essentiality of the epididymal fat pad for spermatogenesis.
William Hansel

Endocrinology· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and pharmacodynamics of Phor21-betaCG(ala), a lytic peptide conjugate.
Lee Jia, Patricia E Noker, Gary A Piazza, Carola Leuschner, William Hansel

J Pharm Pharmacol· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune response to lytic peptides conjugated to a betaCG fragment in treated BALB/C mice.
Marek Bogacki, Frederic M Enright, William J Todd, William Hansel

Reprod Biol· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conjugates of lytic peptides and LHRH or betaCG target and cause necrosis of prostate cancers and metastases.
William Hansel, Carola Leuschner, Fred Enright

Mol Cell Endocrinol· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Destruction of breast cancers and their metastases by lytic peptide conjugates in vitro and in vivo.
William Hansel, Fred Enright, Carola Leuschner

Mol Cell Endocrinol· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LHRH-conjugated magnetic iron oxide nanoparticles for detection of breast cancer metastases.
Carola Leuschner, Challa S S R Kumar, William Hansel, Wole Soboyejo, Jikou Zhou

Breast Cancer Res Treat· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting breast and prostate cancers through their hormone receptors.
Carola Leuschner, William Hansel

Biol Reprod· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Membrane disrupting lytic peptides for cancer treatments.
Carola Leuschner, William Hansel

Curr Pharm Des· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nitric oxide as a local mediator of prostaglandin F2alpha-induced regression in bovine corpus luteum: an in vivo study.
Jerzy J Jaroszewski, Dariusz J Skarzynski, William Hansel

Exp Biol Med (Maywood)· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human prostate cancer cells and xenografts are targeted and destroyed through luteinizing hormone releasing hormone receptors.
Carola Leuschner, Frederick M Enright, Barbara Gawronska-Kozak, William Hansel

Prostate· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of nitric oxide on the secretory function of the bovine corpus luteum: dependence on cell composition and cell-to-cell communication.
Jerzy J Jaroszewski, Dariusz J Skarzynski, Robert M Blair, William Hansel

Exp Biol Med (Maywood)· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Administration of a nitric oxide synthase inhibitor counteracts prostaglandin F2-induced luteolysis in cattle.
Dariusz J Skarzynski, Jerzy J Jaroszewski, Mamadou M Bah, Katarzyna M Deptula, Beata Barszczewska, William Hansel

Biol Reprod· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel approach of targeted ablation of mammary carcinoma cells through luteinizing hormone receptors using Hecate-CGbeta conjugate.
Gabriel Bodek, Nafis Ahmed Rahman, Monika Zaleska, Rabah Soliymani, Hikka Lankinen, William Hansel

Breast Cancer Res Treat· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Membrane disrupting lytic peptide conjugates destroy hormone dependent and independent breast cancer cells in vitro and in vivo.
Carola Leuschner, Frederick M Enright, Barbara Gawronska, William Hansel

Breast Cancer Res Treat· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of a lytic peptide conjugated to beta HCG on ovarian cancer: studies in vitro and in vivo.
Barbara Gawronska, Carola Leuschner, Frederick M Enright, William Hansel

Gynecol Oncol· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis